[A new approach to the therapy of pyoderma in servicemen: the use of the actoprotector bemitil].
Samtsov AV, Tarasenko GN, Smirnov AV · 1998 · Voenno-meditsinskii zhurnal; 1998 May
Study findings
A report involving 51 men with pyoderma described better recovery and selected immune and local inflammatory measures with Bemitil-containing treatment than conventional care.
- Population and setting
- Human report; see summary and review scope
- Evidence type
- Human comparative study
- Preparation
- See the original report; formulation details require verification.
- Source language
- rus
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- Full text and detailed methods have not been independently assessed.
- Allocation, masking, group details and numerical outcomes require full-text appraisal; findings do not establish benefit in healthy users.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and English abstract checked.
Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.
Citation and original source
Original source: Samtsov AV, Tarasenko GN, Smirnov AV. [A new approach to the therapy of pyoderma in servicemen: the use of the actoprotector bemitil]. Voenno-meditsinskii zhurnal; 1998 May 1998.
Molekul research summary: https://molekul.io/research/bemitil-extra-9680838. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry